SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 111.97   2.18 (+1.99%) Volume: 232.45k 4:00 PM EDT 8-Jul-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities105/02/2003
POS AMPost-Effective amendments for registration statement205/01/2003
4Statement of changes in beneficial ownership of securities105/01/2003
4Statement of changes in beneficial ownership of securities105/01/2003
4Statement of changes in beneficial ownership of securities105/01/2003
4Statement of changes in beneficial ownership of securities105/01/2003
4Statement of changes in beneficial ownership of securities105/01/2003
4Statement of changes in beneficial ownership of securities105/01/2003
4Statement of changes in beneficial ownership of securities105/01/2003
DEF 14AOther definitive proxy statements7904/30/2003
8-KCurrent report pursuant to Section 13 or 15(d)204/24/2003
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals304/10/2003
8-KCurrent report pursuant to Section 13 or 15(d)204/02/2003
4Statement of changes in beneficial ownership of securities103/27/2003
10-KAnnual report pursuant to Section 13 or 15(d)9803/21/2003
100101102103104105106107108109110111112113114